SK15692002A3 - 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie - Google Patents
3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie Download PDFInfo
- Publication number
- SK15692002A3 SK15692002A3 SK1569-2002A SK15692002A SK15692002A3 SK 15692002 A3 SK15692002 A3 SK 15692002A3 SK 15692002 A SK15692002 A SK 15692002A SK 15692002 A3 SK15692002 A3 SK 15692002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- substituted
- hydrogen
- groups
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20061700P | 2000-04-28 | 2000-04-28 | |
PCT/CA2001/000581 WO2001083512A1 (en) | 2000-04-28 | 2001-04-30 | 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
SK15692002A3 true SK15692002A3 (sk) | 2003-11-04 |
Family
ID=22742458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1569-2002A SK15692002A3 (sk) | 2000-04-28 | 2001-04-30 | 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie |
Country Status (34)
Country | Link |
---|---|
US (4) | US20040034216A1 (sh) |
EP (1) | EP1278763B1 (sh) |
JP (1) | JP2003531916A (sh) |
KR (1) | KR20030045671A (sh) |
CN (1) | CN1214039C (sh) |
AP (1) | AP1825A (sh) |
AT (1) | ATE353909T1 (sh) |
AU (2) | AU2001252084B2 (sh) |
BG (1) | BG107289A (sh) |
BR (1) | BR0110419A (sh) |
CA (1) | CA2418748A1 (sh) |
CO (1) | CO5590904A2 (sh) |
DE (1) | DE60126597T2 (sh) |
DK (1) | DK1278763T3 (sh) |
DZ (1) | DZ3355A1 (sh) |
EE (1) | EE200200613A (sh) |
ES (1) | ES2282247T3 (sh) |
HK (1) | HK1050694A1 (sh) |
HR (1) | HRP20020944A2 (sh) |
HU (1) | HUP0300908A2 (sh) |
IL (2) | IL152448A0 (sh) |
MA (1) | MA25808A1 (sh) |
MX (1) | MXPA02010645A (sh) |
NO (1) | NO324873B1 (sh) |
NZ (1) | NZ522181A (sh) |
OA (1) | OA12255A (sh) |
PL (1) | PL365798A1 (sh) |
PT (1) | PT1278763E (sh) |
RU (1) | RU2291873C2 (sh) |
SK (1) | SK15692002A3 (sh) |
UA (1) | UA79229C2 (sh) |
WO (1) | WO2001083512A1 (sh) |
YU (1) | YU88102A (sh) |
ZA (1) | ZA200208631B (sh) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
AU2001252084B2 (en) * | 2000-04-28 | 2006-07-06 | Inflazyme Pharmaceuticals Limited | 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
US20050070487A1 (en) * | 2001-04-24 | 2005-03-31 | Nyce Jonathan W. | Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent |
JP2004534042A (ja) | 2001-05-22 | 2004-11-11 | インフラジム ファーマシューティカルズ リミテッド | ステロイド−5−エン化合物のステロイド−5−エン−7−オン化合物へのアリル酸化、続くヒドロホウ素化および酸化による、6,7−ジヒドロキシステロイドの生成のための方法およびこの方法の中間体 |
ES2314252T3 (es) | 2002-08-01 | 2009-03-16 | Astellas Pharma Inc. | Intercambiador de sodio-calcio dependiente del potasio. |
US20090285900A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20110209699A1 (en) * | 2003-07-31 | 2011-09-01 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050026879A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20090263381A1 (en) * | 2003-07-31 | 2009-10-22 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease |
US20050043282A1 (en) * | 2003-07-31 | 2005-02-24 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050026884A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050026881A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease |
US20050113318A1 (en) * | 2003-07-31 | 2005-05-26 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20090297611A1 (en) * | 2003-07-31 | 2009-12-03 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050038004A1 (en) * | 2003-07-31 | 2005-02-17 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050101545A1 (en) * | 2003-07-31 | 2005-05-12 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20090317476A1 (en) * | 2003-07-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20080051382A1 (en) * | 2003-10-20 | 2008-02-28 | Inflazyme Pharmaceuticals Ltd. | Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride |
KR20070007766A (ko) * | 2003-10-20 | 2007-01-16 | 인플라자임 파마슈티칼즈 리미티드 | 3-베타-아미노 17-메틸렌 안드로스테인-6-알파 7-베타-디올하이드로클로라이드의 결정질 형태 |
FR2861077B1 (fr) * | 2003-10-20 | 2006-03-03 | Aventis Pharma Sa | Formes cristallines du chlorydrate de 3-beta-amino, 17-methylene, androstane-6-alpha, 7-beta-diol |
US20050227927A1 (en) * | 2004-03-31 | 2005-10-13 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
US20050222049A1 (en) * | 2004-03-31 | 2005-10-06 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
US20090317477A1 (en) * | 2004-03-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
US9149429B2 (en) * | 2007-11-21 | 2015-10-06 | The Procter & Gamble Company | Preparations, methods and kits useful for the treatment of cough |
JP5655243B2 (ja) * | 2009-10-19 | 2015-01-21 | 国立大学法人 熊本大学 | インドキシル硫酸の産生の阻害剤のスクリーニング方法、インドキシル硫酸代謝産生阻害剤、及び腎障害軽減剤 |
CA2786465C (en) | 2010-01-15 | 2018-09-25 | Suzhou Neupharma Co., Ltd. | Bufalin derivatives for the treatment of cancer |
US9670475B2 (en) | 2010-07-09 | 2017-06-06 | Bioverativ Therapeutics Inc. | Factor IX polypeptides and methods of use thereof |
WO2012103810A1 (en) | 2011-02-02 | 2012-08-09 | Suzhou Neupharma Co., Ltd | Certain chemical entities, compositions, and methods |
WO2013165924A1 (en) * | 2012-04-29 | 2013-11-07 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
EP3542861A1 (en) | 2012-09-25 | 2019-09-25 | Bioverativ Therapeutics Inc. | Methods of using fix polypeptides |
EP2970100A1 (en) | 2013-03-14 | 2016-01-20 | Aquinox Pharmaceuticals (Canada) Inc. | Ship1 modulators and methods related thereto |
JP6407951B2 (ja) | 2013-03-14 | 2018-10-17 | アクイノックス ファーマシューティカルズ (カナダ) インコーポレイテッド | Ship1モジュレーターおよびそれに関連する組成物および方法 |
SG10201707600XA (en) | 2013-03-15 | 2017-11-29 | Biogen Ma Inc | Factor ix polypeptide formulations |
CN104744547B (zh) * | 2013-12-27 | 2017-02-15 | 天津医科大学 | 一种抗乳腺癌转移作用的孕甾烷生物碱衍生物及医药用途 |
WO2016210146A1 (en) | 2015-06-26 | 2016-12-29 | Aquinox Pharmaceuticals (Canada) Inc. | Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol |
WO2017127753A1 (en) | 2016-01-20 | 2017-07-27 | Aquinox Pharmaceuticals (Canada) Inc. | Synthesis of a substituted indene derivative |
CN112543753A (zh) | 2018-04-06 | 2021-03-23 | 塔罗制药公司 | 可用于治疗疼痛和炎症的茚衍生物 |
ES2960542T3 (es) * | 2018-04-06 | 2024-03-05 | Taro Pharmaceuticals Inc | Derivados de hexadecahidro-1H-ciclopenta[a]fenantreno útiles en el tratamiento del dolor y la inflamación |
JP2021526545A (ja) | 2018-04-06 | 2021-10-07 | アキノックス ファーマシューティカルス(カナダ)インク. | 疼痛及び炎症を治療するのに有用なインデン誘導体 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3682983A (en) * | 1969-11-12 | 1972-08-08 | Klaus Prezewowsky | Preparation of {66 {11 {11 -17 ethinyl steroids |
SG50585A1 (en) | 1990-01-18 | 1998-07-20 | Cura Nominees Pty Ltd | Glycoalkaloids |
US5877185A (en) | 1991-10-22 | 1999-03-02 | Octamer, Inc. | Synergistic compositions useful as anti-tumor agents |
CA2086221C (en) * | 1992-12-23 | 2003-07-15 | Raymond J. Andersen | Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |
DE69412596T2 (de) | 1993-03-10 | 1999-03-04 | Magainin Pharmaceuticals Inc., Plymouth Meeting, Pa. | Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel |
US5817632A (en) * | 1993-08-16 | 1998-10-06 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5856535A (en) | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
US6083532A (en) * | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
WO1996036230A1 (en) | 1995-05-16 | 1996-11-21 | The Salk Institute For Biological Studies | Modulators for new members of the steroid/thyroid superfamily of receptors |
US5874597A (en) * | 1995-06-07 | 1999-02-23 | Magainin Pharmaceuticals, Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
US6046185A (en) | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
US6060465A (en) * | 1997-02-06 | 2000-05-09 | Miljkovic; Dusan | Bile acids and their derivatives as glycoregulatory agents |
BR9815711B1 (pt) | 1998-03-06 | 2014-10-29 | Univ Brigham Young | Composto antibiótico derivado de esteróide |
AU2001252084B2 (en) * | 2000-04-28 | 2006-07-06 | Inflazyme Pharmaceuticals Limited | 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
-
2001
- 2001-04-30 AU AU2001252084A patent/AU2001252084B2/en not_active Ceased
- 2001-04-30 CA CA002418748A patent/CA2418748A1/en not_active Abandoned
- 2001-04-30 HU HU0300908A patent/HUP0300908A2/hu unknown
- 2001-04-30 DK DK01925262T patent/DK1278763T3/da active
- 2001-04-30 YU YU88102A patent/YU88102A/sh unknown
- 2001-04-30 CN CNB018101674A patent/CN1214039C/zh not_active Expired - Fee Related
- 2001-04-30 RU RU2002131941/04A patent/RU2291873C2/ru not_active IP Right Cessation
- 2001-04-30 SK SK1569-2002A patent/SK15692002A3/sk unknown
- 2001-04-30 KR KR1020027014524A patent/KR20030045671A/ko not_active Application Discontinuation
- 2001-04-30 US US10/258,950 patent/US20040034216A1/en not_active Abandoned
- 2001-04-30 IL IL15244801A patent/IL152448A0/xx active IP Right Grant
- 2001-04-30 OA OA1200200328A patent/OA12255A/en unknown
- 2001-04-30 BR BR0110419-5A patent/BR0110419A/pt not_active IP Right Cessation
- 2001-04-30 ES ES01925262T patent/ES2282247T3/es not_active Expired - Lifetime
- 2001-04-30 DE DE60126597T patent/DE60126597T2/de not_active Expired - Lifetime
- 2001-04-30 UA UA2002119460A patent/UA79229C2/uk unknown
- 2001-04-30 WO PCT/CA2001/000581 patent/WO2001083512A1/en active IP Right Grant
- 2001-04-30 DZ DZ013355A patent/DZ3355A1/fr active
- 2001-04-30 MX MXPA02010645A patent/MXPA02010645A/es active IP Right Grant
- 2001-04-30 PT PT01925262T patent/PT1278763E/pt unknown
- 2001-04-30 US US09/845,775 patent/US6635629B2/en not_active Expired - Fee Related
- 2001-04-30 EE EEP200200613A patent/EE200200613A/xx unknown
- 2001-04-30 AP APAP/P/2002/002659A patent/AP1825A/en active
- 2001-04-30 NZ NZ522181A patent/NZ522181A/en unknown
- 2001-04-30 JP JP2001580936A patent/JP2003531916A/ja active Pending
- 2001-04-30 EP EP01925262A patent/EP1278763B1/en not_active Expired - Lifetime
- 2001-04-30 AT AT01925262T patent/ATE353909T1/de not_active IP Right Cessation
- 2001-04-30 AU AU5208401A patent/AU5208401A/xx active Pending
- 2001-04-30 PL PL01365798A patent/PL365798A1/xx not_active Application Discontinuation
-
2002
- 2002-10-24 ZA ZA200208631A patent/ZA200208631B/en unknown
- 2002-10-24 IL IL152448A patent/IL152448A/en not_active IP Right Cessation
- 2002-10-24 NO NO20025106A patent/NO324873B1/no unknown
- 2002-11-19 BG BG107289A patent/BG107289A/bg unknown
- 2002-11-20 MA MA26916A patent/MA25808A1/fr unknown
- 2002-11-22 CO CO02106292A patent/CO5590904A2/es not_active Application Discontinuation
- 2002-11-28 HR HR20020944A patent/HRP20020944A2/xx not_active Application Discontinuation
-
2003
- 2003-04-28 HK HK03102993A patent/HK1050694A1/xx not_active IP Right Cessation
- 2003-07-21 US US10/624,946 patent/US7112580B2/en not_active Expired - Fee Related
-
2006
- 2006-07-28 US US11/496,052 patent/US20070060553A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK15692002A3 (sk) | 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie | |
AU2001252084A1 (en) | 3-nitrogen-6,7-dioxygen steroids and uses related thereto | |
JP4606408B2 (ja) | 選択的グルココルチコイド受容体調節物質としての17−カルバモイルオキシコルチゾル誘導体 | |
PH12015500491B1 (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
BR112014026640B1 (pt) | compostos derivados de 2,2-difluoropropionamida de metil bardoxolona, formas polimórficas, composição farmacêutica, e uso dos mesmos | |
DE69703228T2 (de) | Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon | |
US8563742B2 (en) | Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use | |
PT85337B (pt) | Processo para a preparacao de derivados cicloalquilicos 4-piridil-substituidos e de composicoes farmaceuticas que os contem | |
EP0412907A2 (fr) | Nouveaux esters d'acides organiques avec des alcools dérivés de 19-nor stéroides et leurs sels, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions les renfermant | |
DE4227605A1 (de) | Neue Hydroxyimino-5µ,14µ-androstan-Derivate, die auf das kardiovaskuläre System wirken, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die dieselben enthalten | |
JPS6212796A (ja) | 11−β置換ステロイドおよびその製法 | |
DE69409774T2 (de) | Neue kardioaktive 17-Iminomethylalkenyl-5-beta-14-beta-androstan und 17-Iminoalkyl-5-beta, 14-beta-androstan Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon | |
EP0210832A1 (en) | Steroidic aromatase inhibitors | |
DE19961219A1 (de) | 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
DE4232656A1 (de) | Neue Cyclopentanperhydrophenanthren-17beta-(hydroxy oder alkoxy)-17alpha-(aryl oder heterocyclyl)-3beta-derivate, die auf das kardiovaskuläre System wirken, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten | |
JPH0912593A (ja) | 心臓血管系に活性な新規17−ヒドロキシイミノアルキルおよび17−ヒドロキシイミノメチルアルケニルシクロペンタンペルヒドロフェナントレン誘導体、それらの製造方法およびそれらの化合物を含む医薬組成物 |